Skip to main content
Log in

Etorphine Is an Opiate Analgesic Physicochemically Suited to Transdermal Delivery

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. C. E. Inturrisi. Role of opioid analgesics. Am. J. Med. 77(Suppl):27–36 (1984).

    Google Scholar 

  2. T. D. Walsh. Oral morphine in chronic cancer pain. Pain 18:1–11 (1984).

    Google Scholar 

  3. K. M. Foley. The treatment of cancer pain. N. Engl. J. Med. 313:84–95 (1985).

    Google Scholar 

  4. D. S. Shimm, G. L. Logue, A. A. Maltbie, and S. Dugan. Medical management of chronic cancer pain. JAMA 241:2408–2411 (1979).

    Google Scholar 

  5. G. L. Flynn. Topical drug absorption and topical pharmaceutical systems. In G. Banker and C. Rhodes (eds.), Modern Pharmaceutics, Drug Product Design and Evaluation, Marcel Dekker, New York, 1979, pp. 263–327.

    Google Scholar 

  6. R. H. Guy and J. Hadgraft. Mathematical models of percutaneous absorption. In R. L. Bronough and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 3–15.

    Google Scholar 

  7. G. L. Flynn. Mechanism of percutaneous absorption from physicochemical evidence. In R. L. Bronough and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 17–42.

    Google Scholar 

  8. R. C. Wester and H. I. Maibach. Structure-activity correlations in percutaneous absorption. In R. L. Bronough and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 107–123.

    Google Scholar 

  9. S. D. Roy and G. L. Flynn. Transdermal delivery of narcotic analgesics: Comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res. 6:825–832 (1989).

    Google Scholar 

  10. G. F. Blane, L. A. Boura, A. E. Fitzgerald, and R. E. Lister. Actions of etorphine hydrochloride (M99): A potent morphine-like agent. Br. J. Pharmacol. Chemother. 30:11–22 (1967).

    Google Scholar 

  11. G. F. Blane and D. S. Robbie. Trial of etorphine hydrochloride (M99 Reckitt) in carcinoma pain: preliminary report. Proc. Br. Pharmacol. Soc. 2nd–4th 39:252–253 (1970).

    Google Scholar 

  12. A. W. Miser, P. K. Narang, J. A. Dothage, R. C. Young, W. Sindelar, and J. S. Miser. Transdermal fentanyl for pain control in patients with cancer. Pain 37:15–21 (1989).

    Google Scholar 

  13. M. R. Nassiri, G. L. Flynn, and C. Shipman, Jr. Inhibition of cell growth and DNA, RNA and protein synthesis in vitro by fentanyl, sufentanil, and opiate analgesics. J. Pharmacol. Toxicol. 69:17–21 (1991).

    Google Scholar 

  14. S. D. Roy and G. L. Flynn. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Phurm. Res. 7:842–847 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jolicoeur, L.M., Nassiri, M.R., Shipman Jr, C. et al. Etorphine Is an Opiate Analgesic Physicochemically Suited to Transdermal Delivery. Pharm Res 9, 963–965 (1992). https://doi.org/10.1023/A:1015877621976

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015877621976

Navigation